Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: A case control study

Diseases of the Colon and Rectum

Volumn 40, Issue 4, 1997, Pages 451-456

  Lundqvist, Karin ^a   Broomé, Ulrika ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Colectomy; Corticosteroids; Sulfasalazine

Indexed keywords

CORTICOSTEROID; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; ANEUPLOIDY; ARTICLE; CLINICAL TRIAL; COLITIS; COLON DISEASE; COLON RESECTION; COLON TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DYSPLASIA; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SCLEROSING CHOLANGITIS; ULCERATIVE COLITIS;

ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS; CASE-CONTROL STUDIES; CHOLANGITIS, SCLEROSING; COLECTOMY; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; SULFASALAZINE;

EID: 0030956586     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02258391     Document Type: Article

References (23)

1. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. BMJ 1955;2:1041-8.
2. Daniels GE. Psychiatric factors in ulcerative colitis. Gastroenterology 1948;10:59-62.
3. Rampton DS, McNeil NI, Sarner M. Analgesic ingestion and other factors preceding relapse in ulcerative colitis. Gut 1983;24:187-9.
4. Riley SA, Mani VJ, Lucas S. Why do patients with ulcerative colitis relapse? Gut 1990;31:179-83.
5. Olsson R, Danielsson A, Järnerot G, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991;100:1319-23.
6. Broomé U, Glaumann H, Hellers G, Sörstad J, Nillson B, Hultcrantz R. Liver disease in ulcerative colitis: an epidemiological and follow-up study in the county of Stockholm. Gut 1994;35:84-9.
7. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980;80:200-6.
8. Thorpe ME, Scheuer PJ, Sherlock S. Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis. Gut 1967;8:435-48.
9. Aadland E, Schrumpf E, Fausa O, et al. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 1987;22:655-64.
10. Schrumpf E, Fausa O, Forre O, Dobloug JH, Ritland S, Thorsby E. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 1982;17:187-91.
11. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Part IV. Carcinoma of the colon. Gut 1964;5:15-22.
12. Broomé U, Lindberg G, Löfberg R. Primary sclerosing cholangitis in ulcerative colitis - a risk factor for the development of dysplasia and DNA aneuploidy? Gastroenterology 1992;102:1877-80.
13. Broomé U, Löfberg R, Veress B, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis-evidence for increased neoplastic potential. Hepatology 1995;22: 1404-8.
14. Pinczowski D, Ekbom A, Baron J, Yuen J, Adami H-O. Risk factors for colorectal cancer in patients with ulcerative colitis: a case control study. Gastroenterology 1994;107:117-20.
15. Chapman RW, Arborgh BA, Rhodes JM, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography and hepatic histology. Gut 1980;21: 870-7.
16. Evans JG, Acheson ED. An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area. Gut 1965;6:311-24.
17. Nordenvall B, Broström O, Berglund M, Monsén U, Sörstad J, Hellers G. Incidence of ulcerative colitis in Stockholm county 1955-1979. Scand J Gastroenterol 1985;20:311-24.
18. Leijonmarck CE, Persson PG, Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiological study. Gut 1990;31:329-33.
19. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. N Engl J Med 1987;317:1625-9.
20. Seo M, Okada M, Yao T, Ueki M, Arima S, Okumara M. An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 1992;87:971-6.
21. McFarlane IG. Autoreactivity against biliary tract antigens in primary biliary cirrhosis. Mol Aspects Med 1985; 8:249-67.
22. Minuk GY, Angus M, Brickman CM, et al. Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis. Gastroenterology 1985;88:166-70.
23. Zetterquist H, Broome U, Einarsson K, Olerup O. HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis. Gut 1992;33:942-6.